Background Preterm preeclampsia is an important cause of maternal and perinatal death
and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy …

… -19 during the second and third trimester, indicated that the most common symptoms at
presentation were fever and cough; two-third of the patients had lymphopenia and increased C-…

Objective To evaluate the effect of coronavirus disease 2019 (COVID‐19) on maternal,
perinatal and neonatal outcome by performing a systematic review of available published …

Preeclampsia (PE) is a multisystem disorder that typically affects 2%− 5% of pregnant
women and is one of the leading causes of maternal and perinatal morbidity and mortality, …

Objective To examine the performance of screening for early, preterm and term pre‐eclampsia
(PE) at 11–13 weeks' gestation by maternal factors and combinations of mean arterial …

Objectives To assess the cost-effectiveness of the Fetal Medicine Foundation (FMF) combined
first-trimester pre-eclampsia (PE) screening algorithm, coupled with low-dose aspirin …

All units managing hypertensive pregnant women should maintain and review uniform
departmental management protocols and conduct regular audits of maternal & fetal outcomes. …

Global interim guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and
puerperium from FIGO and allied partners: Information for healthcare professionals - Poon - 2020 …

1. EXECUTIVE SUMMARY Fetal growth restriction (FGR) is defined as the failure of the
fetus to meet its growth potential due to a pathological factor, most commonly placental …

Preeclampsia is defined as hypertension arising after 20 weeks of gestational age with
proteinuria or other signs of end-organ damage and is an important cause of maternal and …